These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25240660)

  • 1. Intrathecal pain pumps: indications, patient selection, techniques, and outcomes.
    Bolash R; Mekhail N
    Neurosurg Clin N Am; 2014 Oct; 25(4):735-42. PubMed ID: 25240660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
    Grider JS; Harned ME; Etscheidt MA
    Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal Pain Therapy for the Management of Chronic Noncancer Pain.
    Sukul VV
    Neurosurg Clin N Am; 2019 Apr; 30(2):195-201. PubMed ID: 30898270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Intrathecal Pumps in Nonmalignant Pain.
    Ginalis EE; Ali S; Mammis A
    Neurosurg Clin N Am; 2022 Jul; 33(3):305-309. PubMed ID: 35718400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal delivery of analgesics.
    De Andres J; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2014; 1141():249-78. PubMed ID: 24567144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
    Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
    Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal Drug Delivery.
    De Andrés J; Rubio-Haro R; De Andres-Serrano C; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2020; 2059():75-108. PubMed ID: 31435916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal therapy for chronic pain.
    Miles J
    Stereotact Funct Neurosurg; 2001; 77(1-4):156-8. PubMed ID: 12378067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal analgesia: time to consider it for your patient?
    Shaparin N; Sim A; Pappagallo M; Gritsenko K; Carullo V; Tsukanov J; Kosharskyy B
    J Fam Pract; 2015 Mar; 64(3):166-72. PubMed ID: 25789343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain.
    McDowell GC; Pope JE
    Neuromodulation; 2016 Jul; 19(5):522-32. PubMed ID: 26856969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
    Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
    Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain.
    Pope JE; Deer TR; Amirdelfan K; McRoberts WP; Azeem N
    Curr Neuropharmacol; 2017; 15(2):206-216. PubMed ID: 26861471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic intrathecal drug administration for the control of intractable pain].
    Taira T
    Brain Nerve; 2008 May; 60(5):509-17. PubMed ID: 18516973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ziconotide: an innovative alternative for intense chronic neuropathic pain].
    Valía-Vera JC; Villanueva VL; Asensio-Samper JM; López-Alarcón MD; de Andrés JA
    Rev Neurol; 2007 Dec 1-15; 45(11):665-9. PubMed ID: 18050098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
    Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
    Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study.
    Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM
    Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain.
    Xing F; Yong RJ; Kaye AD; Urman RD
    Curr Pain Headache Rep; 2018 Feb; 22(2):11. PubMed ID: 29404792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal therapy: what has changed with the introduction of ziconotide.
    Kress HG; Simpson KH; Marchettini P; Ver Donck A; Varrassi G
    Pain Pract; 2009; 9(5):338-47. PubMed ID: 19740270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.